Skip to main content

Diagnostics

  • Provided issuer-side representation to Quanterix Corporation in its $64.1M public offering (IPO) underwritten by JP Morgan; Leerink Partners; Cowen and Company; BTIG; and Evercore ISI.
  • Represented QIAGEN N.V. in multiple transactions, including its $260M acquisition of the digital pcr assets of Formulatrix, Inc., its $234M strategic partnership with NeuMoDx Molecular, Inc., its $105M acquisition of Ingenuity Systems, Inc., as well as its $97.5M acquisition of SA Biosciences Corporation.
  • Defended Enzymatics against claims of trade secrets theft and patent infringement brought by three plaintiffs in a case involving nucleic acid ligands. Resulted in favorable settlement for our client.
  • Conducted a freedom to operate assessment for a client which produces a clinical diagnostic product, essentially a lab-on-a-chip which provides for point of care testing for a wide range of infections. Most such tests have to be conducted at a central laboratory, which increases expense and causes a significant wait for results. The company's product allows treatment professionals to carry out testing on-site. We reviewed numerous third-party patents to advise the company that it had freedom to operate.
Case Study
Check out UNITED NOTIONS, a new report on M&A activity in the life sciences sector. Produced in collaboration with Mergermarket, the report provides a comprehensive look at the health of deal activity in the industry and an insightful view of current trends as compared to a year ago.
Case Study
Mintz and Mergermarket produced a comprehensive report on recent M&A activity in the life sciences sector. We asked 100 US-based executives to share what motivated their latest transaction and their post-closing integration experiences.
Case Study
Mintz successfully led a national diagnostics company through a series of informal investigative inquiries from the Department of Justice and formal responses to subpoenas issued by the Office of Inspector General.
Case Study
Professionals in Mintz's Patent Prosecution & Strategic Counseling Practice advise Roche Molecular Systems on various patent matters. Mintz has managed the client’s patent portfolio since Roche Molecular acquired Ariosa Diagnostics and its non-invasive prenatal test “Harmony.
Case Study
Mintz is defending a major diagnostics company in a False Claims Act qui tam case filed by a former employee. The Department of Justice declined to intervene in the case, which involves allegations of managed care fraud. Mintz has filed a motion to dismiss and objections to discovery request